Afelimomab

Afelimomab (MAK 195F) is an anti-tumor necrosis factor monoclonal antibody. Afelimomab can be used for the research of sepsis[1].

Product Specifications

CAS Number

[156227-98-4]

Product Name Alternative

MAK 195F

UNSPSC

12352203

Target

TNF Receptor

Type

Inhibitory Antibodies

Related Pathways

Apoptosis

Applications

COVID-19-immunoregulation

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/afelimomab.html

Purity

99.34

Solubility

10 mM in DMSO

Smiles

[Afelimomab]

Molecular Weight

(145.82 kDa)

References & Citations

[1]Edward A Panacek, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F (ab') 2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004 Nov;32 (11) :2173-82.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

TU168421 1.0 mL

Scn3a 3'UTR GFP Stable Cell Line

View Details

NB100-65611AF647 0.1 mL

Armenian Hamster Monoclonal CD79B Antibody (HM79-11) [Alexa Fluor 647]

View Details

EK00202E 96 Tests

Human THBS1/Thrombospondin-1 ELISA Kit

View Details

G8235-58F-FITC 200 µL

Glypican 6, NT (Glypican-6, GPC6, MGC126288, OMIMD1, UNQ369/PRO705) (FITC) discontinued

View Details

ORF056692 1.0 µg DNA

Sbk1 ORF Vector (Mouse) (pORF)

View Details

EIA05390h 1 Kit

Human Breast Cancer Susceptibility Protein 2 (BRCA2) ELISA Kit

View Details